Intellia Therapeutics Announces First Quarter 2025 Financial Results and Highlights Recent Company Progress

Go back to Intellia Therapeutics Announces First Quarter 2025 Financial Results and Highlights Recent Company Progress
(NASDAQ: NTLA) Delayed: 15.75 --0 (-0%)
Previous Close $15.75    52 Week High $30.40 
Open $15.75    52 Week Low $11.86 
Day High $15.75    P/E N/A 
Day Low $15.75    EPS $0.00 
Volume 37,754